Therefore, the changes in HSP levels we observed after 8 weeks of CMS accompanied by depressive-like behavior and reversed by IMI treatment, at least in the group of treatment responders, underlie the mechanism of depression. This evidence concerns the gene HSP90B2P and depressive symptom measurement.